Page last updated: 2024-08-18

pyridostigmine bromide and Cranial Nerve III Diseases

pyridostigmine bromide has been researched along with Cranial Nerve III Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agba, AI; Apetse, K; Ayena, KD; Balo, KP; Balogou, KA; Diatewa, BM; Domingo, SA; Maneh, N1
Thanigasalam, T; Ting, HS; Yashodhara, BM; Yousuf, UA1

Other Studies

2 other study(ies) available for pyridostigmine bromide and Cranial Nerve III Diseases

ArticleYear
[Juvenile myasthenia gravis in sub-Saharan Africa: a case study of two consanguine sisters born from consanguinity in Togo].
    The Pan African medical journal, 2017, Volume: 28

    Topics: Age of Onset; Child; Consanguinity; Disease Progression; Female; Humans; Lost to Follow-Up; Myasthenia Gravis; Oculomotor Nerve Diseases; Pyridostigmine Bromide; Refractive Errors; Togo; Visual Acuity

2017
"Why do I always see double?" A misdiagnosed case of ocular myasthenia gravis for 10 years.
    BMJ case reports, 2014, May-02, Volume: 2014

    Topics: Anti-Inflammatory Agents; Blepharoptosis; Cholinesterase Inhibitors; Diagnosis, Differential; Diagnostic Errors; Diplopia; Humans; Male; Middle Aged; Myasthenia Gravis; Oculomotor Nerve Diseases; Prednisolone; Pyridostigmine Bromide

2014